Summary & Overview

HCPCS H0049: Alcohol and/or Drug Screening

HCPCS Level II code H0049 denotes an alcohol and/or drug screening service, a brief assessment using standardized tests to detect recent substance use. This screening is an important tool in behavioral health and primary care settings for early identification of substance misuse and for triaging patients to appropriate interventions. Nationally, substance use screening supports population health efforts, quality measurement, and linkage to care.

Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of typical billing contexts, payer coverage patterns, common modifiers, and service-line implications where available. The publication covers benchmarking points, payer policy highlights, and clinical context relevant to screening workflows and sites of service.

The report provides concise guidance on administrative considerations for claims involving HCPCS Level II code H0049, highlights common billing modifiers associated with screening services, and summarizes what is known about settings where screenings are performed. Data not available in the input are noted where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareH0049HCPCS Level IIalcohol screeningdrug screeningbehavioral healthoutpatientambulatory carescreening servicessubstance use

Billing Code Overview

HCPCS Level II code H0049 describes alcohol and/or drug screening. This service represents brief standardized testing to determine the presence of alcohol or controlled substances in an individual.

Service type: Screening service for substance use
Typical site of service: Outpatient clinics, behavioral health settings, community-based treatment programs, and other ambulatory care locations where substance use screening is performed

Data not available in the input.

Clinical & Coding Specifications

Clinical Context

A 28-year-old male presents to an outpatient behavioral health clinic for intake after employer-mandated testing following a workplace incident. The clinician documents recent risky alcohol consumption and orders an alcohol and/or drug screening to confirm substance use. The typical clinical workflow includes brief history and consent, specimen collection (urine or breath), point-of-care immunoassay screening or collection for laboratory confirmatory testing, documentation of results in the medical record, and communication of findings to the referring employer or treatment team as permitted by privacy rules. Specimen handling follows chain-of-custody procedures when testing is for legal or occupational purposes. Billing for the encounter includes the screening service represented by H0049; additional services such as counseling, confirmatory laboratory testing, or medical evaluation are billed separately using appropriate CPT/HCPCS codes and modifiers as needed.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when substantially greater work than typical screening is documented, such as complex specimen handling or extended counseling tied directly to the screening encounter.
`23`	Unusual anesthesia	Not commonly used for `H0049`; reserved for rare circumstances requiring anesthesia during specimen collection procedures.
`26`	Professional component	Use when billing separates the professional interpretation/reporting component of a laboratory or point-of-care test from the technical component.
`52`	Reduced services	Use when the screening service is partially performed or abbreviated but still reportable.
`53`	Discontinued procedure	Use if the screening was started but terminated for patient safety reasons before completion.
`54`	Surgical care only	Not typically applicable; included for completeness when professional and global packages are split.
`55`	Postoperative management only	Not applicable to routine screening but may apply if bundled surgical care is involved.
`56`	Preoperative management only	Rarely applicable; use if the screening is performed solely as preoperative clearance.
`62`	Two surgeons	Uncommon for this service; included when two providers of different specialties share responsibility for screening-related procedures.
`AS`	Physician assistant, nurse practitioner, or clinical nurse specialist services for assistant-at-surgery	Not typically relevant; included when advanced practice clinicians document role in collection under supervision.
`TC`	Technical component	Use when billing only the technical component (laboratory processing) of the screening test.
`QK`	Medical direction by a physician (3–4 concurrent)	Apply when billing modifiers related to medical direction of specific ancillary services where applicable.
`QX`	CRNA service: medical direction by a physician	Rarely applicable; include only if anesthesia services intersect with testing.
`QY`	Medical director	Use when a physician provides medical direction of the service and that distinction must be captured.

Taxonomy Code	Specialty	Notes
`163W00000X`	Addiction Medicine	Common specialty ordering and interpreting drug and alcohol screening.
`2084P0802X`	Clinical Social Worker	Performs behavioral health assessments and facilitates screening in outpatient settings.
`208D00000X`	Psychiatry & Neurology	Psychiatrists frequently order and review substance use screenings.
`363L00000X`	Laboratory Director	Oversees technical components and lab processing for confirmatory testing.
`371K00000X`	Family Medicine	Primary care clinicians commonly order initial alcohol/drug screening.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`F10.20`	Alcohol dependence, uncomplicated	Common indication for alcohol screening and monitoring.
`F11.20`	Opioid dependence, uncomplicated	Indicates opioid use disorder for which drug screening is clinically relevant.
`F12.20`	Cannabis dependence, uncomplicated	Screening used to document ongoing cannabis use in clinical management.
`F13.20`	Sedative, hypnotic or anxiolytic dependence, uncomplicated	Screening helps identify benzodiazepine or sedative misuse.
`F15.20`	Other stimulant dependence, uncomplicated	Stimulant screening may be performed when stimulant use disorder is suspected.
`Z13.89`	Encounter for screening for other disorder	Generic screening encounter code that may accompany substance use screening events.
`R78.0`	Finding of drugs in blood	Used when screening or confirmatory testing detects drugs in the bloodstream.
`R78.82`	Finding of alcohol in blood	Used to report positive alcohol testing results.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`80307`	Drug screen, presumptive, any number of drug classes, any method; each procedure	Commonly performed as a point-of-care or laboratory presumptive immunoassay screening that complements `H0049`.
`80306`	Drug test, presumptive, qualitative; multiple drug classes	Alternative presumptive screen code used for multi-panel rapid tests associated with the screening visit.
`80305`	Drug test, presumptive, qualitative; single drug class	Used when only a single-substance screen (e.g., ethanol) is performed along with the `H0049` service.
`80320`	Drug confirmation by definitive methodology, e.g., GC/MS, LC/MS/MS	Performed after a positive presumptive screen to confirm specific substances; typically billed by the laboratory separately.
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes	Often billed alongside `H0049` when a clinician performs evaluation and brief counseling during the same visit.
`99408`	Alcohol and/or substance abuse structured screening and brief intervention services, 15 to 30 minutes	May be reported when structured SBI is provided in addition to the screening test represented by `H0049`.